HBAN vs SCNI · P/E 13, rev $1.56B vs P/E 0.2, rev $1.3M
Huntington Bancshares Incorporated (HBAN) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the HBAN and SCNI stock pages for the full models.
Not investment advice.